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Background: Biodegradable polymers have increasingly been 
recognized for various biological applications in recent years. 
Here we examined the immunostimulatory activities of the 
novel poly(aspartic acid) conjugated with L-lysine (PLA). 
Methods: PLA was synthesized by conjugating L-lysine to as-
partic acid polymer. PLA-nanoliposomes (PLA-NLs) were 
prepared from PLA using a microfluidizer. The immunostim-
ulatory activities of PLA-NLs were examined in mouse bone 
marrow-derived dendritic cells (BM-DCs). Results: PLA-NLs 
increased the number of BM-DCs when added to cultures of 
GM-CSF-induced DC generation on day 4 after the initiation 
of cultures. Examination of the phenotypic properties show-
ed that BM-DCs generated in the presence of PLA-NLs are 
more mature in terms of the expression of MHC class II mol-
ecules and major co-stimulatory molecules than BM-DCs 
generated in the absence of PLA-NLs. In addition, the 
BM-DCs exhibited enhanced capability to produce cyto-
kines, such as IL-6, IL-12, TNF-α and IL-1β. Allogeneic 
mixed lymphocyte reactions also confirmed that the BM- 
DCs were more stimulatory on allogeneic T cells. PLA- NL al-
so induced further growth of immature BM-DCs that were 
harvested on day 8. Conclusion:  These results show that 
PLA-NLs induce the generation and functional activities of 
BM-DCs, and suggest that PLA-NLs could be immunostim-
ulating agents that target DCs. 
[Immune Network 2011; 11(5):281-287]
INTRODUCTION
The importance of polymers with biodegradability and bio-
compatibility has increasingly been recognized for various bi-
ological applications. Biodegradable polymers based on both 
natural and synthetic polymers are widely used as viscosity 
agents, emulsifying agents, and carriers for delivery of drugs 
or active ingredients in medical, cosmetic, and other industrial 
fields  (1,2). 
    Poly-glutamic acid (PGA), for instance, is an anionic poly-
mer that is composed of D- and L-glutamic acid units (3,4). 
PGA is produced by Bacillus subtilis during fermentation of 
soybeans. Recent reports have demonstrated immune modu-
latory activities of PGA or its derivatives (5-7). Nanoparticles 
composed of PGA and L-phenylalanine ethylester served as 
an adjuvant that was able to activate dendritic cells and en-
hance adaptive immune responses against antigens carried by 
the  nanoparticles  (8,9). 
    Poly(aspartic acid), which is one of the poly(amino acid)s 
and biodegradable synthetic polymers, is a water-soluble pol-
yamide containing carboxylic pendants that can be obtained 
from the hydrolysis of polysuccinimide (10,11), the thermal 
polycondensation product of L-aspartic acid (12,13). Due to 
their amphiphilic uniqueness, amino acid polymers contain-
ing  both  hydrophilic  and  hydrophobic  components  can  be 
used to stabilize dispersions, emulsions, and polymer blends 
(14,15). PLA-NLs Induce the Generation and Functional Activities of BM-DCs
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Table I. Recipes used to prepare PLA-NLs
PLA-NL-1 PLA-NL-2
A) Lecithin (%)   3.00 -
Phosphatidyl 
          serine (%) -   6.00
Lysolecithin (%)   1.00 -
Caprylic/Capric 
        Triglyceride (%) - 10.00
Sucrose palmitate (%)   3.00   3.00
Ethanol (%)   5.00   5.00
H2O Make to 100 ml Make to 100 ml
B) EDTA-2Na (%)   0.01   0.01
Sodium ascorbyl 
          phosphate (%)   0.30   0.30
B-1) Ethanol (%) 10.00 10.00
PLA (%) 10.00 10.00
    L-lysine is one of the most important amino acids and has 
been  known  to  have  various  biological  functions  including 
regulation of cytokine synthesis and lymphocyte proliferation 
(16-18).  L-lysine  is  also  important  to  the  collagen  structure 
in  connective  tissue  in  skin,  ligaments,  cartilage,  vertebral 
discs, joint linings, capillary walls, bones and teeth (16). L-ly-
sine components conjugated to the polymer backbone have 
specific biological functions in vivo and a unique pH-sensitive 
property (19,20). Poly (L-lysine) has been widely used as a 
gene delivery carrier due to its strong ability to protect DNA 
from  nuclease  attack  (21). 
    Liposomes, spherical nanoparticles with an aqueous com-
partment, possess the unique ability to effectively deliver both 
water-soluble  compounds  (in  the  aqueous  phase)  and  lip-
id-soluble  compounds  (in  the  lipid  bilayer)  (22,23).  More-
over, liposomes rapidly penetrate the dermal barrier, making 
the delivery of water-soluble compounds as effective as that 
of lipid-soluble compounds (24). In contrast with other drug 
carriers such as DMSO (25), liposomes are entirely non-toxic 
to human skin since they are composed of naturally occurring 
biodegradable  compartments  (26). 
  In this work, novel liposomes composed of biodegradable 
polymers based on poly(aspartic acid) conjugated with L-ly-
sine  (PLA-NLs)  were  prepared  from  PLA  using  a  micro-
fluidizer.  The  immunomodulatory  activities  of  PLA-NLs  on 
bone  marrow  derived-dendritic  cells  (BM-DCs)  were  then 
investigated. The present study showed that PLA-NLs induce 
the  generation  and  functional  activities  of  BM-DCs.
MATERIALS AND METHODS
Preparation of PLA-nanoliposomes (PLA-NLs)
Polymers  of  L-aspartic  acid  and  L-lysine-conjugated  poly 
(aspartic acid), PLA, were prepared as described previou-
sly (2,27). The powdery product was filtered out and dried 
under vacuum at 40
oC for three days to obtain PLA as a 
yellowish  white  powder  (yield  81%). 
    PLA-NLs were prepared from PLA as described in Table I. 
The  phases  described  in  Table  I,  A,  B  and  B-1,  were  dis-
solved at 70
oC, respectively. The dissolved A phase was add-
e d  t o  t h e  m i x e d  p h a s e  o f  B  a n d  B - 1  a n d  t h e n  t h i s  m i x e d 
solution was passed through a microfluidizer (M110F, Micro-
fluidic,  USA)  three  times  at  1000  bar  to  prepare  PLA-NLs.
    The  average  size  of  PLA-NL-1  and  PLA-NL-2  was  70  nm 
and  200  nm,  respectively,  when  measured  using  a  particle 
size  analyzer  (ELS-Z,  Photal,  Japan).
    PLA-NL-1 was a nanoliposome made of lecithin and PLA- 
NL-2  was  a  nanoliposome  made  of  phosphatidyl  serine.
Cell culture
Cells were cultured in Dulbecco's modified Eagle's medium 
(Hyclone  Laboratories,  Inc.,  UT,  USA)  supplemented  with 
10% heat-inactivated fetal bovine serum (Hyclone), 100 U/ml 
penicillin and 100μg/ml streptomycin (Hyclone), and 50μM 
2-mercaptoethanol  (SIGMA-ALDRICH,  Inc.,  St.  Louis,  MO, 
USA)  at  37
oC  i n  a  5 %  C O 2  atmosphere.
Generation of bone marrow derived dendritic cells 
(BM-DCs)
BM-DCs were generated from total bone marrow cells as de-
scribed previously (28). Briefly, bone marrow cells obtained 
from femurs of C57BL/6 mice were cultured in 6-well plates 
(5×10
6/well) in culture medium supplemented with 40 ng/ml 
GM-CSF (CreaGene, Seongnam, Korea). At days 3 and 4 after 
the initiation of the culture, nonadherent cells were discarded 
by  gentle  shaking  and  replacing  the  culture  medium  with 
fresh  medium  containing  GM-CSF.  BM-DCs  were  harvested 
by gentle pipetting on day 8. In experiments examining the 
effects of PLA-NLs, PLA-NLs were added to the culture on day 
4 after the initiation of the culture, and the resultant BM-DCs 
were  harvested on  day 8  and used for phenotypic analysis 
and  functional  assays.
Proliferation assay
BM-DCs harvested on day 8 were cultured in the presence PLA-NLs Induce the Generation and Functional Activities of BM-DCs 
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Figure 1. PLA-NLs increase the generation of 
BM-DCs. Mouse BM-DCs were generated from 
C57BL/6 mouse BM cells. BM cells were 
cultured with the indicated concentration of 
PLA-NLs and GM-CSF (40 ng/ml). PLA-NLs were
added to the culture on day 4 after the initiation
of the BM cell culture, and the resultant BM-DCs 
were harvested on day 8 and counted using a 
hemocytometer. Results are mean±SD. *p＜0.05
compared with untreated control.
of  different  concentrations  of  PLA-NLs  in  96-well  microtiter 
plates  (2×10
4  cells/well).  DNA  synthesis  was  measured  by 
[
3H]-thymidine (PerkinElmer) incorporation (0.5μCi/well) for 
the final 16 h of the 2-day culture period. The cells were har-
vested onto glass fiber filter paper using a cell harvester. The 
filters were washed, dried, and then counted in a microbeta 
liquid  scintillation  counter  (Wallac,  USA).
Allogeneic mixed lymphocyte reaction (MLR)
BM-DCs  were  treated  with  mitomycin  C  (SIGMA-ALDRICH) 
for 20 min at 37
oC, washed three times with culture medium, 
and then adjusted to 5×10
4 cells/ml. Responder T cells were 
isolated from spleens of BALB/c mice by a nylon wool-en-
richment technique and adjusted to 5×10
5 cells/ml. Each 100 
μl of cell suspension was mixed and cultured in 96-well mi-
crotiter plates. DNA synthesis was measured by [
3H]- thymi-
dine (PerkinElmer) incorporation (0.5μCi/well) for the final 
16 h of the 3-day culture period. The cells were harvested 
onto glass fiber filter paper using a cell harvester. The filters 
were washed, dried, and then counted in a microbeta liquid 
scintillation  counter  (Wallac,  USA).
Cytokine production
BM-DCs were cultured in the presence of different con-
centrations  of  PLA-NLs  with  OVA-containing  nanoparti-
cles (50μg/ml as OVA) in 12-well microtiter plates (1× 
10
6  cells/well/2  ml).  Nanoparticles  containing  OVA  were 
prepared using a homogenization/solvent evaporation meth-
od using poly(lactic-co-glycolic acid), as described previously 
(29). After 24-h incubation, the culture supernatants were col-
lected,  and  the  amounts  of  IL-12,  IL-6,  IL-1β and  TNF-α 
were measured using commercial immunoassay kits (BD Bio-
sciences,  San  Diego,  CA,  USA)  according  to  the  manufac-
turer’s  instructions.
Flow cytometry
Cells  were  stained  with  monoclonal  antibodies  recognizing 
murine cell surface markers as described previously (30), and 
flow cytometric analysis was performed on a FACSCanto II 
(BD  Biosciences).  The  monoclonal  antibodies,  anti-ICAM-1 
(clone  3E2),  anti-I-A
b  (clone  AF6-120.1),  anti-B7-1  (clone 
16-10A1), anti-B7-2 (clone GL1), and isotype-matched control 
antibodies were purchased from BD Biosciences. Dead cells 
were  gated out  by their low forward angle light  scatter in-
t e n s i t y .  I n  m o s t  a n a l y s e s ,  1 0 , 0 0 0  c e l l s  w e r e  s c o r e d .
Statistical analysis
Data were expressed as mean±SD. The statistical significance 
of  the  difference  between  the  control  group  and  treatment 
g r o u p  w a s  a s s e s s e d  b y  a  o n e - w a y  A N O V A  f o l l o w e d  b y  a  
Student's  t-test.
RESULTS
PLA-NLs increase the generation of BM-DCs from BM 
cells
To examine the effects of PLA-NLs on the growth and matura-
tion of BM-DCs, PLA-NLs were added to the cultures of BM 
cells on day 4 after the initiation of the culture, and the re-
sultant BM-DCs were harvested on day 8. As shown in Fig. 
1A, addition of PLA-NL-1 (0.1 mg/ml) to cultures of BM cells 
increased the number of BM-DCs that were harvested on day 
8  b y  a p p r o x i m a t e l y  7 6 %  c o m p a r e d  t o  t h e  G M - C S F  o n l y  
control. PLA-NL-2 (0.1 mg/ml) also increased the number of 
BM-DCs by approximately 74% compared to the GM-CSF only 
control (Fig. 1). Addition of 1 mg/ml of PLA-NLs to BM cells PLA-NLs Induce the Generation and Functional Activities of BM-DCs
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Figure 2. PLA-NLs induce phenotypic maturation of 
BM-DCs. PLA-NLs (0.1 mg/ml) were added to BM cell 
culture together with GM- CSF (40 ng/ml) on day 4 after
the initiation of cultures, and the resultant BM-DCs were
harvested on day 8, washed, and then used for 
immunophenotypic analysis. Levels of expression (thin 
line) in BM-DCs generated in the presence of GM-CSF 
and PLA-NLs are illustrated in comparison with those in
BM-DCs generated in the presence of GM-CSF only 
(shaded line).
Figure 3. DCs generated in the presence of PLA-NLs 
exert increased capability to produce cytokines. 
PLA-NLs (0.1 mg/ml) were added to BM cell cultures 
together with GM-CSF (40 ng/ml) on day 4 after the 
initiation of cultures, and the resultant BM-DCs were 
harvested on day 8 and then cultured with OVA-conta-
ining nanoparticles (50μg/ml as OVA). After 24 h, cyto-
kines were measured by ELISA. Results are mean±SD.
*p＜0.05, **p＜0.01 compared with untreated control.
appeared  to  be  toxic  to  the  cells.
PLA-NLs induce phenotypic maturation of BM-DCs
Because increased expression of cell surface molecules could 
be a marker of dendritic cell activation, we examined the ef-
fect of PLA-NLs on the expression levels of MHC class II and 
co-stimulatory molecules in BM-DCs that were harvested on 
day 8. As shown in Fig. 2, BM-DCs that were generated in 
medium containing GM-CSF without PLA-NLs stimulation ex-
hibited  characteristics  of  immature  DCs  based  on  staining 
with I-A
b, B7-1, B7-2 and ICAM-1 molecules. In contrast, the 
BM-DCs  generated  in  the  presence  of  PLA-NLs  exhibited 
more mature phenotypes. The expression levels of I-A
b, B7-1, 
B7-2  and  ICAM-1  molecules  were  significantly  increased  in 
BM-DCs generated in the presence of PLA-NLs. The effects 
of  PLA-NL-1  and  PLA-NL-2  on  the  phenotypic  changes  ap-
p e a r e d  t o  b e  s i m i l a r .
DCs generated in the presence of PLA-NLs exhibit an 
increased capability to produce cytokines
Because  PLA-NLs  appeared  to  induce  differentiation  of 
BM-DCs,  the  cytokine  producing  capability  of  BM-DCs  that 
were  generated  in  the  presence  of  PLA-NLs  was  compared 
with  that  of  control BM-DCs.  BM-DCs  that  were  stimulated 
with  OVA-containing  poly(lactic-co-glycolic  acid)  nano-
particles  (50μg / m l  a s  O V A )  f o r  2 4  h ,  c u l t u r e  s u p e r n a t a n t s  
were collected from the stimulated BM-DCs, and the amounts 
of IL-6, IL12, IL-1β and TNF-α were measured by ELISAs. PLA-NLs Induce the Generation and Functional Activities of BM-DCs 
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Figure 5. PLA-NLs induce the proliferation of GM-CSF-generated 
BM-DCs. The DCs generated in the presence of 40 ng/ml of GM-CSF 
only were harvested on day 8, and then cultured with the indicated
concentration of PLA-NLs. After 2 days, the growth of BM-DCs was 
measured by [
3H]-thymidine incorporation. Results are mean±SD. *p
＜0.05, **p＜0.01 compared with untreated control.
Figure 4. DCs generated in the presence of PLA-NLs exert increased 
allostimulatory capacity. PLA-NLs (0.1 mg/ml) were added to BM cell
cultures together with GM-CSF (40 ng/ml) on day 4 after the initiation
of cultures, and the resultant BM-DCs were harvested on day 8. All
BM-DCs were treated with mitomycin C, washed, and then cultured
with allogeneic mouse lymphocytes. After 3 days, cell growth was 
measured by [
3H]-thymidine incorporation. Results are mean±SD. *p
＜0.01 compared with untreated control.
As shown in Fig. 3, the BM-DCs that were generated in the 
presence of PLA-NLs produced significantly enhanced levels 
of  all  the  cytokines  that  were  examined. 
　It has previously been shown that DCs cultured in the pres-
ence  of  OVA-containing  poly(lactic-co-glycolic  acid)  nano-
particles produce large amounts of cytokines (31). The pres-
ent study shows that BM-DCs generated in the presence of 
PLA-NLs produced even further increased levels of cytokines 
when  stimulated  with  OVA-containing poly(lactic-co-glycolic 
acid)  nanoparticles.
DCs generated in the presence of PLA-NLs exhibit 
increased allostimulatory capacity
The allostimulatory capacity of BM-DCs generated in the pres-
ence of PLA-NLs was examined in allogeneic mixed lympho-
cyte reactions. As shown in Fig. 4, control BM-DCs that were 
generated in medium containing GM-CSF only induced low 
to  moderate  proliferation  of  allogeneic  T  cells.  In  contrast, 
BM-DCs  that  were  generated  in  the  presence  PLA-NLs  ex-
hibited  significantly  enhanced  allostimulatory  capacity.  The 
proliferation of allogeneic T cells was increased by approx-
imately  220%  when  BM-DCs  generated  in  the  presence  of 
PLA-NLs were used as stimulatory cells compared to BM-DCs 
generated in GM-CSF only. Since all the BM-DCs were treated 
with mitomycin C and subsequently washed thoroughly to re-
move  mitomycin  C,  the  T  cell  proliferation  must  be  a  re-
flection  of  increased  BM-DC  function.
PLA-NLs induce further proliferation of BM-DCs
To examine the effects of PLA-NLs on the further growth of 
immature BM-DCs, immature BM-DCs were harvested on day 
8 and then cultured for 2 days in the presence or absence 
of  PLA-NLs.  During  this  2-day  culture  period,  GM-CSF  was 
not  added  to  the  culture  medium.  As  shown  in  Fig.  5, 
BM-DCs that were harvested on day 8 did not proliferate ac-
tively  when  cultured  in  GM-CSF-free  medium.  In  contrast, 
BM-DCs  that  were  harvested  on  day  8  proliferated  sig-
nificantly  when  cultured  in  the  presence  of  PLA-NLs  (1 
mg/ml).
DISCUSSION
The  present  study  shows  that  PLA-NLs  exert  significant im-
munostimulating activity on DCs. It has been well-established 
that DCs can be generated from bone marrow stem cells by 
culturing in the presence of a high dose of GM-CSF (32). To 
examine the effects of PLA-NLs on the generation of BM-DCs 
from BM cells, PLA-NLs were added to BM cells cultures to-
gether with GM-CSF on day 4 after the initiation of cultures. 
BM-DCs were harvested on day 8, and the numbers, pheno-
type  and  functional  characteristics  of  the  cells  were  exam-
ined.
　The present study shows that PLA-NLs when added to BM 
cell  cultures  together  with  GM-CSF  induce  phenotypic  and 
functional maturation of the BM-DCs. In addition, PLA-NLs in-PLA-NLs Induce the Generation and Functional Activities of BM-DCs
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duced the proliferation of immature DCs. The proliferation-in-
ducing  activity  of  PLA-NLs  was  observed  not  only  when 
PLA-NLs were added to BM-cell cultures on day 4 after ini-
tiation  of  culture,  but  also  when  PLA-NLs  were  added  to 
BM-DCs that were harvested on day 8. When added to cul-
tures of immature DCs, PLA-NLs induced phenotypic matura-
tion as evidenced by up-regulation of class II MHC molecules 
and  co-stimulatory  molecules  such  as  I-A
b,  B7-1,  B7-2  and 
ICAM-1. 
　The  DCs  cultured  with  PLA-NLs  (0.1  mg/ml)  exhibited 
more potent allogeneic T cell stimulatory activity and induced 
the proliferation of GM-CSF-generated BM-DCs. DCs can rec-
ognize and process antigens in the periphery and then mi-
grate to secondary lymphoid organ where they prime primary 
T cell responses (33). The capability of DCs to activate naive 
T cells in a primary response has been explained by their abil-
ity to express high levels of class II MHC and co-stimulatory 
molecules (34). The immature DCs must be matured or further 
activated  in  order  to  fully  perform  accessory  cell  functions 
(35). Maturation signals appear to be very diverse and include 
inflammatory cytokines such as TNF-α and IL-1β (36). It is 
noteworthy  that  1  mg/ml  PLA-NLs  appeared  to  be  toxic  to 
the cells when they were added to very early stage of DC 
generation (day 4 from the initiation of the culture) (Fig. 1). 
H o w e v e r ,  P L A - N L s  d i d  n o t  e x e r t  c y t o t o x i c  a c t i v i t y  o n  i m -
mature BM-DCs that were harvested on day 8 from the ini-
tiation  of  the  culture  (Fig.  5).  At  1  mg/ml  concentration, 
PLA-NLs even increased the proliferation of day-8 immature 
DCs. The underlying mechanism for the differential effects is 
not  clear  at  present.
    These results show that PLA-NLs induce the generation and 
functional  activities  of  BM-DCs.  Both  types  of  PLA-NLs, 
PLA-NL-1  and  PLA-NL-2,  exerted  similar  stimulatory  activity 
on  BM-DCs.
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